AI Verdict
OCUL has stronger fundamentals based on our AI analysis.
ODYY vs OCUL Fundamental Comparison
| Metric | ODYY | OCUL |
|---|---|---|
| Revenue | $0.0 | $52.0M |
| Net Income | $-4.1M | $-265.9M |
| Net Margin | N/A | -511.9% |
| ROE | N/A | -40.6% |
| ROA | -566.3% | -32.9% |
| Current Ratio | 0.06x | 15.39x |
| Debt/Equity | N/A | 0.04x |
| EPS | $-0.04 | $-1.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ODYY vs OCUL: Frequently Asked Questions
Is ODYY or OCUL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OCUL has stronger fundamentals. ODYY is rated STRONG SELL (92% confidence) while OCUL is rated SELL (72% confidence). This is not investment advice.
How does ODYY compare to OCUL fundamentally?
Odyssey Health, Inc. has ROE of N/A vs OCULAR THERAPEUTIX, INC's -40.6%. Net margins are N/A vs -511.9% respectively.
Which stock pays higher dividends, ODYY or OCUL?
ODYY has a dividend yield of N/A or no dividend while OCUL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ODYY or OCUL for long term?
For long-term investing, consider that ODYY has STRONG SELL rating with 92% confidence, while OCUL has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ODYY vs OCUL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ODYY vs OCUL, the AI consensus favors OCUL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.